Valacyclovir to expedite the clearance of recurrent herpes gladiatorum

Clinical Journal of Sport Medicine

Volumn 15, Issue 5, 2005, Pages 364-366

  Anderson, B J ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE   (United States)

Author keywords

Herpes gladiatorum; HSV 1; Valacyclovir; Wrestling

Indexed keywords

ANTIVIRUS AGENT; PLACEBO; VALACICLOVIR;

ADULT; ARTICLE; ATHLETE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; HERPES; HERPES GLADIATORUM; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; TREATMENT OUTCOME; WRESTLING;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; POLYMERASE CHAIN REACTION; RECURRENCE; TREATMENT OUTCOME; VALINE; WRESTLING;

EID: 25444448529     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jsm.0000181468.44397.ce     Document Type: Article

References (8)

1. Submitted for publication.
2. Anderson BJ. Valacyclovir for prevention of reactivation of herpes gladiatorum in wrestlers. Clin J Sport Med. 1999;9:86-90.
3. NCAA. 2003 Wrestling Championships Handbook. Indianapolis, IN: NCAA; 2003:WR-29.
4. National Federation of State High School Associations Wrestling Handbook. Indianapolis, IN: 2002.
5. Anderson BJ, Clark A, Tillman D. Valacyclovir for prevention of reactivation of herpes gladiatorum in wrestlers: an updated study. AJMS. 2003;5: 309-314.
6. Thackray A, Field H. Famciclovir and valacyclovir differ in the prevention of herpes simplex virus type I latency in mice: a quantitative study. Antimicrob Agents Chemother. 1998;42:1555-1562.
7. Spruance S, Jones T, Blatter M, et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother. 2003;47:1072-1080.
8. Soul-Lawton J, Seaber E, On N, et al. Absolute bioavailability and metabolic disposition of valacyclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother. 1995;39:2759-2764.